close

For more than four decades, Fenwick & West LLP has helped some of the world’s most recognized companies become, and remain, market leaders. From emerging enterprises to large public corporations, our clients are leaders in the technology, life sciences and cleantech sectors and are fundamentally changing the world through rapid innovation.  MORE >

Fenwick & West was founded in 1972 in the heart of Silicon Valley—before “Silicon Valley” existed—by four visionary lawyers who left a top-tier New York law firm to pursue their shared belief that technology would revolutionize the business world and to pioneer the legal work for those technological innovations. In order to be most effective, they decided they needed to move to a location close to primary research and technology development. These four attorneys opened their first office in downtown Palo Alto, and Fenwick became one of the first technology law firms in the world.  MORE >

From our founding in 1972, Fenwick has been committed to promoting diversity and inclusion both within our firm and throughout the legal profession. For almost four decades, the firm has actively promoted an open and inclusive work environment and committed significant resources towards improving our diversity efforts at every level.  MORE >

At Fenwick, we are proud of our commitment to the community and to our culture of making a difference in the lives of individuals and organizations in the communities where we live and work. We recognize that providing legal services is not only an essential part of our professional responsibility, but also an excellent opportunity for our attorneys to gain valuable practical experience, learn new areas of the law and contribute to the community.  MORE >

Year after year, Fenwick & West is honored for excellence in the legal profession. Many of our attorneys are recognized as leaders in their respective fields, and our Corporate, Tax, Litigation and Intellectual Property Practice Groups consistently receive top national and international rankings, including:

  • Named Technology Group of the Year by Law360
  • Ranked #1 in the Americas for number of technology deals in 2015 by Mergermarket
  • Nearly 20 percent of Fenwick partners are ranked by Chambers
  • Consistently ranked among the top 10 law firms in the U.S. for diversity
  • Recognized as having top mentoring and pro bono programs by Euromoney

MORE >

We take sustainability very seriously at Fenwick. Like many of our clients, we are adopting policies that reduce consumption and waste, and improve efficiency. By using technologies developed by a number of our cleantech clients, we are at the forefront of implementing sustainable policies and practices that minimize environmental impact. In fact, Fenwick has earned recognition in several areas as one of the top US law firms for implementing sustainable business practices.  MORE >

At Fenwick, we have a passion for excellence and innovation that mirrors our client base. Our firm is making revolutionary changes to the practice of law through substantial investments in proprietary technology tools and processes—allowing us to deliver best-in-class legal services more effectively.   MORE >

Mountain View Office
Silicon Valley Center
801 California Street
Mountain View, CA 94041
650.988.8500

San Francisco Office
555 California Street
13th Floor
San Francisco, CA 94104
415.875.2300

Seattle Office
1191 Second Avenue
10th Floor
Seattle, WA 98101
206.389.4510

New York Office
1211 Avenue of the Americas
32nd Floor
New York, NY 10036
212.921.2001

Shanghai Office
Unit 908, 9/F, Kerry Parkside Office
No. 1155 Fang Dian Road
Pudong New Area, Shanghai 201204
P.R. China
+86 21 8017 1200


Life Sciences Public Offerings Alive in 2015

February 05, 2015

Fenwick & West securities co-chair Rob Freedman was featured in a Law360 article about 2015 shaping up to be an even stronger year than 2014 for life sciences companies’ public offerings and eager investors buying in. For example, Fenwick’s most recent venture capital survey found that seven of the eight initial public offerings in January were for life sciences companies.

​Freedman said that with the number of companies coming into the public market, one way to stand out and attract investor interest is to have a record of strong private financings or a solid pharmaceutical company partnership in advance of an initial public offering.

“[Private investors] often raise funds just before or even overlapping the IPO,” Freedman said. “If you can get these private investors interested, you are taking in some cash now, reducing the overall risk, it can be a fairly large sum to move your clinical trials forward.”

“Mezzanine financing is also a bit of a stamp of approval on a company,” he added.

Freedman also credited the Jumpstart Our Business Startups Act of 2012, also known as the Jobs Act, with creating a more inviting and less risky environment for emerging life sciences companies by creating the confidential registration process and making the entire process less expensive.

“The ability to get in line without the world knowing, and then when market conditions look right, being able to jump into your IPO just a few weeks later, that makes it much less of a gamble for companies,“ Freedman said. “The Jobs Act also reduced costs. If you are only raising $50 million in an IPO versus a tech company that might raise a billion, the fact that it costs less reduces another risk of going forward.”

Being able to test-drive their offering with potential investors has enabled companies to crystallize their message and determine if an IPO is the best way for them to proceed, Freedman noted. He pointed to the steady increase in life sciences offerings since 2012 as evidence that the Jobs Act helped smaller companies get a surer foothold in this competitive environment.

The full article is available through the Law360 website​.​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​